Qinghai Spring Medicinal Resources Technology Co., Ltd. (SHA:600381)
China flag China · Delayed Price · Currency is CNY
4.200
+0.070 (1.69%)
Sep 30, 2026, 3:00 PM CST

SHA:600381 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
273.28339.03264.68206.78155.05123.89
Other Revenue
4.374.395.587.095.133.88
277.65343.42270.26213.88160.18127.76
Revenue Growth
8.14%27.07%26.36%33.52%25.37%2.81%
Cost of Revenue
197.42212.07203.4986.27138.5147.78
Gross Profit
80.23131.3566.77127.6121.68-20.02
Selling, General & Admin
123.81129.47193.44222.37188.41118.56
Research & Development
12.849.7714.5611.6411.389.54
Other Operating Expenses
7.754.494.333.082.933.19
Operating Expenses
151.19148.96223.16246.81229.43189.87
Operating Income
-70.97-17.6-156.39-119.2-207.75-209.89
Interest Expense
-0.05-0.21-0.67-0.91-0.09-0.05
Interest & Investment Income
14.9113.091.131.360.50.17
Currency Exchange Gain (Loss)
-1.69-0.052.64-0.13-0.881.33
Other Non Operating Income (Expenses)
-0.21-0.731.22-0.31-0.525.79
EBT Excluding Unusual Items
-58.01-5.51-152.07-119.2-208.74-202.64
Gain (Loss) on Sale of Investments
-9.88-9.9-36.9-139.81-46.96-51.13
Gain (Loss) on Sale of Assets
-0.240.02-0.1100.02-0.02
Asset Writedown
-13.66-13.66-7.9-0.03-40.68-
Legal Settlements
------0.02
Other Unusual Items
5.994.04-4.23-1.251.091.35
Pretax Income
-75.8-25.02-201.2-260.28-295.27-252.46
Income Tax Expense
-0.8911.06-3.895.93-7.72-3.84
Earnings From Continuing Operations
-74.91-36.08-197.31-266.21-287.55-248.61
Minority Interest in Earnings
0.18-1.24-1.46-1.650-
Net Income
-74.73-37.32-198.77-267.87-287.55-248.61
Net Income to Common
-74.73-37.32-198.77-267.87-287.55-248.61
Net Income Growth
------
Shares Outstanding (Basic)
505533585582587592
Shares Outstanding (Diluted)
505533585582587592
Shares Change
-18.65%-8.80%0.39%-0.77%-0.86%0.03%
EPS (Basic)
-0.15-0.07-0.34-0.46-0.49-0.42
EPS (Diluted)
-0.15-0.07-0.34-0.46-0.49-0.42
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
2.73-32.9676.0410.39-32.64-185.73
Free Cash Flow Per Share
0.01-0.060.130.02-0.06-0.31
Gross Margin
28.89%38.25%24.71%59.67%13.53%-15.67%
Operating Margin
-25.56%-5.13%-57.86%-55.73%-129.70%-164.28%
Profit Margin
-26.92%-10.87%-73.55%-125.24%-179.52%-194.59%
Free Cash Flow Margin
0.98%-9.60%28.14%4.86%-20.38%-145.37%
EBITDA
-56.13-1.03-136.06-97.52-167.01-168.29
EBITDA Margin
-20.22%-0.30%-50.34%-45.60%-104.27%-131.72%
D&A For EBITDA
14.8416.5720.3221.6840.7441.59
EBIT
-70.97-17.6-156.39-119.2-207.75-209.89
EBIT Margin
-25.56%-5.13%-57.86%-55.73%-129.70%-164.28%
Revenue as Reported
277.65343.42270.26213.88160.18127.76
Advertising Expenses
-26.7369.6379.8-24.65